Price Chart

Profile

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
URL https://www.adagene.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 28, 2024 (est.)
Last Earnings Release Aug. 31, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
URL https://www.adagene.com
Investor Relations URL N/A
HQ State/Province N/A
Sector Healthcare
Industry Biotechnology
Equity Style N/A
Next Earnings Release Mar. 28, 2024 (est.)
Last Earnings Release Aug. 31, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A